Lithuanian digital health startup making allergy and food intolerance testing accessible and affordable across Europe. Addresses the problem of allergy misdiagnosis affecting nearly half of Europeans.
Valuation: €2.56M (2025); est. ~€5-10M €2.56M (2025)